A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
Clinical trial NCT04747964 · COMPLETED
Trial details
- NCT number
- NCT04747964
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2021-04-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.